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Abstract
Background: Despite the widespread occurrence of axon and synaptic loss in the injured and diseased nervous
system, the cellular and molecular mechanisms of these key degenerative processes remain incompletely
understood. Wallerian degeneration (WD) is a tightly regulated form of axon loss after injury, which has been
intensively studied in large myelinated fibre tracts of the spinal cord, optic nerve and peripheral nervous system
(PNS). Fewer studies, however, have focused on WD in the complex neuronal circuits of the mammalian brain, and
these were mainly based on conventional endpoint histological methods. Post-mortem analysis, however, cannot
capture the exact sequence of events nor can it evaluate the influence of elaborated arborisation and synaptic
architecture on the degeneration process, due to the non-synchronous and variable nature of WD across individual
axons.
Results: To gain a comprehensive picture of the spatiotemporal dynamics and synaptic mechanisms of WD in the
nervous system, we identify the factors that regulate WD within the mouse cerebral cortex. We combined single-
axon-resolution multiphoton imaging with laser microsurgery through a cranial window and a fluorescent
membrane reporter. Longitudinal imaging of > 150 individually injured excitatory cortical axons revealed a
threshold length below which injured axons consistently underwent a rapid-onset form of WD (roWD). roWD
started on average 20 times earlier and was executed 3 times slower than WD described in other regions of the
nervous system. Cortical axon WD and roWD were dependent on synaptic density, but independent of axon
complexity. Finally, pharmacological and genetic manipulations showed that a nicotinamide adenine dinucleotide
(NAD+)-dependent pathway could delay cortical roWD independent of transcription in the damaged neurons,
demonstrating further conservation of the molecular mechanisms controlling WD in different areas of the
mammalian nervous system.
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Conclusions: Our data illustrate how in vivo time-lapse imaging can provide new insights into the spatiotemporal
dynamics and synaptic mechanisms of axon loss and assess therapeutic interventions in the injured mammalian
brain.
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Background
Axon degeneration leads to loss of connectivity and
brain function upon trauma including head injury and
stroke. Understanding the mechanisms of axon degener-
ation to either prevent or delay it, therefore, represents a
promising avenue to develop effective therapies for these
brain disorders [1].
Axonal injury is followed by degeneration of the distal
part of the axon that is detached from the soma. This
tightly controlled process of axon self-elimination follow-
ing a lesion is termed WD [2] and has been intensively
studied and characterised with the aim of devising new
strategies to treat neurodegenerative and other diseases
[1], which typically manifest with prominent local axon
degeneration preceding cell body loss. Even though the
triggering signals may be different, the execution phase of
WD and axon degeneration in neurodegenerative diseases
is conserved [3–7]. This common final axon removal step
includes degradation of axoplasmic neurofilaments and
microtubules, axon thinning, beading, fragmentation and
clearance by resident glial cells [2, 8, 9].
Due to the limitations of current techniques, several
aspects of WD remain to be fully established. WD is
characterised by a protracted and variable lag phase be-
fore fragmentation which can take 24–48 h [3, 10–13].
Previous studies have suggested that the progression of
WD depends on the length of the disconnected segment,
with longer segments taking longer to degenerate than
shorter ones [7, 12]. This length-based mechanism is
consistent with the presence of axon protective factors
such as NAD+ or the NAD+ synthesising enzymes,
which when depleted from the axon trigger the process
of fragmentation [14–17], with longer disconnected seg-
ments having inherently higher levels of such protective
factors compared to shorter ones. This idea has been dif-
ficult to test because of the challenge of measuring the
length of axons before a lesion in the living brain or
spinal cord.
Existing, widely used experimental models are fo-
cussed on injured large myelinated fibres of the optic
nerve [18, 19], spinal cord [20–25] and PNS [13, 26–29].
In particular, in vivo optical imaging has enabled funda-
mental discoveries on axon degeneration in the optic
nerve [18] and spinal cord [20, 23, 25], e.g. the first de-
scription of Acute Axonal Degeneration (AAD), a form
of WD occurring within minutes of injury, and of clin-
ical relevance, as it removes portions of axon still con-
nected to the soma and synapses near the lesion site
[20], or of axon branch specific degeneration [25]
(reviewed in [30], [31]). Whether similar or different
mechanisms underlie the degeneration process in com-
plex axonal networks such as those of the adult brain,
however, is unknown. In particular, we lack critical in-
formation on the potential regulatory roles of axon
branching and synaptic density and on how they might
influence the degeneration process.
Most investigations of axon degeneration use cyto-
solic or cytoskeletal reporters [13, 18, 20, 22, 23, 27–
29, 32], and as such, the kinetics and mechanisms of
fragmentation of the surrounding axolemma remain
unexplored. There are a handful of reports—in cul-
tured peripheral neurons and the drosophila nervous
system—noting increased resilience of the axonal
membrane compared to cytosolic and cytoskeletal
axonal components (microtubules, neurofilaments),
which are affected first [4, 15]. To ensure the pro-
gression of axon degeneration can be followed to
completion, it is therefore necessary to characterise
the dynamics of axolemmal degeneration in vivo.
Axons constitute the largest neuronal compartment,
surpassing the size of the cell body 1000-fold, in both
length and surface area [33]. They can extend for up to
10 cm in the mouse brain [34] and branch thousands of
times to reach all their targets [35]. As a result, it has
not been possible to follow the degeneration process for
individual unmyelinated cortical axons, an intricate fibre
network vulnerable in many brain disorders, leaving the
detailed spatiotemporal progression and synaptic mecha-
nisms uncharted. High-energy lasers can be non-
invasively directed with high precision to specific axonal
segments, causing localised axonal breakage [25]. Laser
microsurgery and live imaging have been successfully
combined in the past to study axon regeneration in C.
elegans [36] and the mouse brain [37–39], and for the
study of spinal cord [23, 40] and retinal ganglion cell
nerve injury [41], as well as stroke [42].
Here, we established and validated the combination
of in vivo multiphoton time-lapse microscopy with
laser microsurgery and a fluorescent membrane re-
porter to capture, for the first time, the cellular
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dynamics and regulatory mechanisms of cortical axon
degeneration for up to 6 days post injury. We report
four main findings: First, we identified a threshold
length (~ 600 μm) below which damaged axonal end-
ings consistently started fragmenting on average 20
times earlier than longer segments. Segments longer
than ~ 600 μm degenerated with kinetics more in line
with WD described in other regions of the nervous
system. Second, cortical axon WD depended on syn-
aptic density but not on the complexity of the axonal
arbour. Third, AAD was less prominent in cortical
unmyelinated axons than in spinal cord axons. Finally,
a local NAD+-dependent pathway delayed cortical
WD, independently of gene transcription in the dam-
aged neuron. Our data support the use of longitudinal
multiphoton in vivo imaging of fluorescent membrane
markers and laser microsurgery to gain new insights
into axon and synaptic degeneration and evaluate
treatment strategies in the injured cerebral cortex.
Results
Single-axon-resolution imaging of Wallerian degeneration
in the living brain
In order to study the progression of WD at single axon
resolution over several days in the mammalian brain, we
implanted cranial windows over the mouse somatosen-
sory cortex [43] and combined 2-photon imaging with a
well-established microlesion paradigm based on femto-
second laser-mediated subcellular ablation [36, 40]
(Fig. 1a, b). To monitor the integrity of the axonal mem-
brane in real-time [4, 7], we opted for a membrane-
targeted form of GFP under the Thy1.2 promoter, which
in the cerebral cortex drives expression of the transgene
predominantly in excitatory cells of cortical layers 2/3/5/
6 and thalamic origin [44]. To demonstrate the power of
this methodology for the study of cortical axon WD, we
describe several applications aimed at shedding light on
the time course and regulatory factors of degeneration
in injured neocortical circuits.
Fig. 1 Single-axon-resolution imaging of axon degeneration in the living brain. a Timeline of imaging and injury to study cortical axon
degeneration in vivo. b A region of axon ready for lesioning (left); a binary mask (4 μm) is placed over the axon (green circle) and a focused laser
beam used to induce axotomy, verified by imaging immediately after lesion (right). Proximal is up and distal is down. c Representative drawings
of axon segments before lesioning used throughout the study. Black filled circles indicate terminal axon endings. d A representative axon before
lesioning, total length 1289 μm. e Representative drawings of the disconnected portion of the axon in the dotted box in d illustrating axonal
degeneration over selected time points. Time in hours post-lesion and percentage of axon remaining are indicated. f Representative example of
quantification of the degeneration onset (23 h) and g calculation of fragmentation rate for the axon in d, e (1.45 μm/min). Scale bar = 5 μm (b),
150 μm (c), 200 μm (d) and 300 μm (e)
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A rapid onset form of Wallerian degeneration
Individual cortical axons were identified as terminal end-
ings and transected using a laser-mediated lesion
(Fig. 1b–d) [37–39] to generate disconnected axon seg-
ments of known length from the edge of the lesion site
to the terminal ending (range 0.12–1.5 mm). The onset
(Fig. 1e, f) and rate (Fig. 1e, g) of fragmentation were cal-
culated for each axon by detailed analysis of sequentially
captured images. To determine the onset and rate of
fragmentation, severed axons were imaged at regular in-
tervals of up to 5 h (or for a subset of 8 axons less than
2 h, see methods) and the time point of the imaging ses-
sion immediately preceding the first sign of clearly vis-
ible break in the axon (i.e. fragmentation) recorded as
the ‘onset time’. A decrease in length of more than
10 μm over two consecutive sessions and a clear break
in the axon shaft was considered as degeneration. At
each subsequent imaging session, the sum of the individ-
ual fragment lengths was expressed as a percentage of
the length of the disconnected axon immediately prior
to fragmentation. The gradient (m) of the resulting slope
was used to calculate the fragmentation rate using the for-
mula y =mx + c (where c is the y intercept). We found that
shorter disconnected axons, < ~ 600 μm in length, started
the degeneration process by fragmenting significantly earl-
ier than longer segments, > ~ 600 μm in length (Fig. 2a, b,
Additional file 1). Relating the length and onset times for
38 transected cortical axons suggested the presence of two
types of degeneration responses (Fig. 2c).
Following this observation of bimodality within the
axon length and fragmentation onset time data, we
sought to rigorously test the existence of two popula-
tions. The two Gaussian components of these bimodal
distributions were fitted using the R mixtools packages
(Version 1.0.2). The mean and standard deviations were
calculated for these modelled Gaussian components, and
the upper 95% confidence intervals of the components
with the lower mean within both the onset time and
length measurements identified. This allowed for the
classification of a subset of data points as significant out-
liers to the lower components of both onset time and
length. This subclass of data points was found to have
significantly higher mean onset times compared to the
rest of the data (p < 0.01, Wilcoxon rank sum test). In-
deed, tracking individual injured axons continuously for
up to 153 h at < 5 h intervals to capture the onset of
fragmentation showed that longer transected axonal seg-
ments (typically > 600 μm from the ending; mean =
973 ± 65 μm, n = 17 axons from 14 mice) consistently
initiated fragmentation after 19–127 h in line with the
relatively slow onset described in the WD literature (15
out of 17 examples, i.e. 88%, Fig. 2a, d, e). In contrast,
shorter transected axonal segments (typically < 600 μm
from the ending; mean = 339 ± 32 μm, n = 21 axons
from 13 mice) consistently initiated fragmentation on
average ~ 20 times earlier than the longer portions (20
out of 21 examples, i.e. 95%; Fig. 2b, d, e, < 600 μm, on-
set time = 1.7 ± 0.4 h, n = 21; > 600 μm, onset time =
40.0 ± 8.7 h, n = 17, p < 0.0001), via a process we termed
rapid onset WD (roWD). However, despite falling into
two clear groups, we found no correlation between the
time of onset of fragmentation and the actual length of
each disconnected axon ending within each group
(Fig. 2f, < 600 μm undergoing roWD onset time versus
length, R2 = 0.08, p > 0.05; Fig. 2g, > 600 μm undergoing
WD, R2 = 0.07, p > 0.05).
These results are consistent with the possibility
that the distal portion of the axon, within 600 μm
from the ending, has a different competency for de-
generation compared to more proximal locations (>
600 μm from the ending). To test this idea, we used
laser microsurgery to cut equal-length segments
from different regions along the axon—either located
within 600 μm of the axon ending (distal), or further
back along the axon shaft where the axon fragment
generated was located more than 600 μm from the
end (proximal). We induced lesions at either end of
both segments so that both the distal and the prox-
imal segments were comparable (double lesion (dis-
tal) and double lesion (proximal), Fig. 3a). For the
double lesion (proximal) segment experiment, this
also generated a second segment that contained the
axon ending and was at least 600 μm in length—this
segment was ignored for the purpose of this experi-
ment. We found no difference in the degeneration
onset time between these two groups of axon seg-
ments (double lesion (distal) and double lesion
(proximal), p > 0.05, Fig. 3b). In some cases, we were
able to cut two equal length axon segments sepa-
rated by at least 600 μm from each other along the
same axon (Fig. 3b; n = 5 axons from 3 mice, grey
lines linking data points) and found again no differ-
ence in the degeneration onset (p > 0.05). These data
suggest that the location of the disconnected axon
segments along the axon does not affect the kinetics
of the degeneration process.
An alternative possibility to explain the faster degener-
ation onset in shorter axon segments is that a threshold-
dependent mechanism controls the kinetics of cortical
roWD and WD [7]. This threshold model, whereby the
initiation of axon degeneration could be mediated by the
loss of a protective factor and/or the accumulation of a
degeneration trigger (see discussion, and illustrated in an
additional file (Additional file 2)), predicts that axonal
segments of the same length with two cut ends would
have earlier fragmentation onset than equal length seg-
ments having only one cut end, owing to two depletion/
accumulation routes, instead of one.
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Fig. 2. A rapid onset form of Wallerian degeneration in the adult cortex. a Representative images of a long axon ending undergoing
Wallerian degeneration (WD) with time post-lesion and percentage of axon lost indicated. b Representative images of a shorter axon
ending undergoing rapid onset WD (roWD) with time post-lesion and percentage of axon lost indicated. c Scatter plot indicating the
presence of two axonal populations with different onset time of fragmentation. d Surviving length of each in vivo injured axon (n = 38)
over the time points indicated illustrating a population undergoing roWD (blue lines). e Histogram demonstrating significant early onset
time of fragmentation of axons < 600 μm in length (roWD, blue) compared to longer axons (WD, grey). Mean ± SEM. Mann Whitney U
test. ****p < 0.0001. f, g No correlation between roWD onset time and length (f, n = 21 axons < 600 μm from 13 mice, p > 0.05) or for
longer axons undergoing WD (g, n = 17 axons > 600 μm from 14 mice, p > 0.05). Scale bar: 135 μm (a), 70 μm (b). For further examples of
fragmenting axons as in panels a-b, see Additional file 1
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Fig. 3 Probing axon degeneration kinetics in vivo. a Schematic illustrating single and double lesion experiments from different regions of the
axon. b Average fragmentation onset time for double lesioned distal axons (black circles, n = 13 axons, 10 mice), double lesioned proximal axons
(open circles, n = 8 axons, 7 mice) and single lesioned axons (blue circles, n = 18 axons, 9 mice). Grey lines link data points from double lesioned
distal and proximal segments along the same axon (n = 5 axons, 3 mice). Wilcoxon test, *** p < 0.001. c Slower fragmentation rate of shorter
axons undergoing roWD (blue points) compared to longer axons undergoing WD (grey points) after a single axonal lesion, **** p < 0.0001. d No
correlation between roWD fragmentation rate and axon length (blue points, n = 21 axons, 13 mice, p > 0.05) or for longer axon WD
fragmentation rate and axon length (e, grey points, n = 14 axons, 14 mice, p > 0.05)
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So, we compared the double lesion (distal) data set
(mean length = 187 ± 18 μm, n = 13 axons, 10 mice) with
the original data collected for axon segments generated
by a single lesion within a known distance of the ter-
minal ending (Fig. 3a. single lesion, mean length = 310 ±
30 μm, n = 18 axons, 8 mice). The double lesion segments
showed a significantly earlier onset of fragmentation com-
pared to the single lesion axons (Fig. 3b, single lesion on-
set = 134 ± 24min; double distal lesion onset = 34 ± 19
min; p = 0.001), as predicted by the threshold-dependent
axon degeneration model. To further explore whether the
double lesion had to flank the distal ending to generate
this effect, we also compared the single lesion onset time
to the double lesion (proximal) segments located more
than 600 μm from the ending (n = 8 axons, 7 mice). Simi-
larly, this showed a trend towards a significantly earlier
onset time in the double (proximal) axons segments com-
pared to the single lesions (Fig. 3b, single lesion onset =
134 ± 24min; double proximal lesion onset = 66 ± 33min;
p = 0.0512). This supports a threshold-dependent model
to explain the onset of degeneration in transected cortical
axons.
To further investigate the degeneration kinetics of
roWD and WD, using a single lesion paradigm, we com-
pared the fragmentation rates of the surviving axon seg-
ments once fragmentation onset was detected.
Surprisingly, the rate of fragmentation for shorter trans-
ected axonal segments (< 600 μm from the ending) was
significantly slower than for longer transected axonal seg-
ments (Fig. 3c, < 600 μm, 0.5 ± 0.1 μm/min, n = 21 axons,
13 mice; > 600 μm, 1.6 ± 0.2 μm/min, n = 14 axons, 14
mice; p < 0.0001). Similar to the onset time, within each
group, there was no correlation between the length of the
disconnected axon segments and the fragmentation rate
(Fig. 3d, e, < 600 μm, R2 = 0.08, p > 0.05; > 600 μm, R2 =
0.07, p > 0.05), again ruling out a linear length-based
mechanism to explain the degeneration kinetics.
Using a similar image analysis approach, we inves-
tigated the site of the first observed fragmentation
along injured cortical axons. Out of 32 axons, 10
started fragmenting close to the lesion site, 11 from
the terminal ending furthest from the lesion, 5 along
the entire length at the same time, 3 from the mid-
dle and 3 from both ends simultaneously, with dif-
ferent regions displaying comparable onset (close to
lesion site, onset time = 7.3 ± 2.4 h, n = 26; distal end,
onset time = 10.4 ± 2.9 h, n = 26, p > 0.05) and frag-
mentation speed (close to lesion end, 0.19 ±
0.035 μm/min, n = 16; distal end, 0.19 ± 0.038 μm/
min, n = 16, p > 0.05). Intriguingly, when we divided
the axons into two groups, shorter or longer than
600 μm, despite the low numbers, fragmentation in
shorter axons undergoing roWD was significantly
more likely to start at the distal axon ending (40%
of lesioned axons) compared to longer axons under-
going WD (10% of lesioned axons; Chi squared test,
p < 0.001).
Cortical WD depends on bouton density but not axonal
arbour complexity
Laser microsurgery and in vivo imaging of individual
grey matter axons opens the way to study the role of
axonal arborisation and synaptic architecture in WD,
which could not be assessed in previous work on large
myelinated fibres of the spinal cord, optic nerve or the
PNS. So, we asked how the density of boutons along
cortical axons and the complexity of axonal arborisation
affects roWD and WD. We hypothesised that axons with
a relatively high density of synaptic contacts may take
longer to degenerate than axons with lower synaptic
density due to the molecular complexity within the axon
and the additional time required to disassemble the syn-
aptic machinery [15], even though axons with a greater
synapse density would have a greater energetic burden.
The bouton density (range 0.0048–0.0957 boutons/μm)
of 33 axons was quantified on the basis of morphology
(terminaux boutons TB) in the distal axon segment prior
to the laser micro-lesion, with all protrusions between 1
and 5 μm extending from the midline of the axonal shaft
considered as boutons. These axonal structures have
previously been confirmed as forming complete synapses
[38, 44, 45]. The bouton density was correlated with the
onset and rate of fragmentation of the same segments
(Fig. 4a, b). For segments > 600 μm undergoing WD,
bouton density significantly correlated with the onset
(R2 = 0.30, p < 0.05; Fig. 4c) but not the rate of fragmen-
tation (R2 = 0.03, p > 0.05; Fig. 4e, n = 13 axons, 13 mice).
For segments < 600 μm undergoing roWD, bouton dens-
ity also significantly correlated with the onset (R2 = 0.44
p < 0.01; Fig. 4d), but not with the rate of fragmentation
(R2 = 0.08, p > 0.05; Fig. 4f, n = 20 axons, 12 mice). These
data support the hypothesis that the onset of fragmenta-
tion in axons undergoing degeneration is dependent on
the synaptic connectivity within the axon segment,
where higher bouton density results in a later onset of
fragmentation but has no significant relationship to the
kinetics of fragmentation once commenced.
Investigation of kinetics in branched and un-
branched axons showed no difference in onset times
(unbranched > 600 μm, 24.7 ± 8.0 h, n = 5 axons, 5
mice; branched > 600 μm, 24.3 ± 7.7 h, n = 5 axons, 5
mice, p > 0.05; unbranched < 600 μm, 1.80 ± 0.45 h,
n = 15 axons, 8 mice; branched < 600 μm, 1.81 ± 0.74
h, n = 4 axons, 3 mice, p > 0.05) or fragmentation
rates (unbranched > 600 μm, 1.81 ± 0.39 min; branched
> 600 μm, 1.92 ± 0.49 min, p > 0.05; unbranched <
600 μm, 0.44 ± 0.06 min; branched < 600 μm, 0.54 ±
0.12 min, p > 0.05), suggesting that axonal arbor
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complexity does not play a major role in cortical
axon degeneration kinetics.
AAD is less prominent than roWD and WD in injured
cortical axons in vivo
Frequent regular imaging immediately after transection
revealed little evidence of cortical axon fragmentation
occurring within the first 60 min post-lesion, either
proximal [39] or distal to the lesion site as illustrated in
an additional movie file (see Additional file 3), with all
but one disconnected axonal segments (37 out of 38,
97%) exhibiting a delay in fragmentation onset of at least
1 h (Fig. 5a). Significant axonal fragmentation (~ 200–
300 μm) on both sides of the lesion within few minutes
of injury, however, was reported in the myelinated fibres
of spinal cord [20] and optic nerve [18]. This difference
Fig. 4 Synaptic boutons delay the onset of degeneration in cortical axons. a, b Representative images of axons with relatively low (a) and high
(b) densities of terminaux boutons (TBs). c, d There is a significant correlation between bouton density and the onset of fragmentation for
segments undergoing WD (c, p < 0.05, n = 13 axons, 13 mice) and for shorter axons undergoing roWD (d, p < 0.01, n = 20 axons, 12 mice). e, f
There is no correlation between bouton density and fragmentation rate for segments undergoing WD (e, p > 0.05) or roWD (f, p > 0.05). Scale bar
40 μm (a, b)
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could be due to different lesion methods (laser versus
mechanical axotomy), markers used (axonal membrane
versus cytosolic) or intrinsic characteristics of the differ-
ent neuronal populations in the nervous system (cerebral
cortex, spinal cord, optic nerve).
To investigate these possibilities, we performed laser
axotomies and in vivo imaging in both the ascending
dorsal white matter tracts in the spinal cord (where
AAD was first described [20]) and in cortical axons
using either cytosolic (GFP-M line [46]) or axolemmal
GFP markers (L15 line [47, 48]), expressed under the Thy
1.2 promoter. In vivo time-lapse imaging of individual as-
cending spinal axons (see Additional file 4) showed that
while the axoplasm (cytosol and cytoskeletal components)
fragmented within minutes in the proximity of the spinal
cord lesion (GFP-M line, axoplasm degeneration onset =
29.6 ± 4min; range 16–56min, n = 9 axons, 5 mice) (Add-
itional file 4a, c) consistent with previously described AAD
[23], the membrane near the lesion site remained intact for
up to ~ 4 h (L15 line, axolemmal onset = 139.9 ± 22min;
range 58–228min, n = 9 axons, 5 mice; p < 0.001 compared
to axoplasmic onset) (Additional file 4b, c). Analysis of the
position of the two severed axon tips, proximal and distal
to the lesion site, showed that the axonal membrane under-
went almost no retraction from the lesion site in the first
60min on either side of the lesion (L15 line, proximal tip
8.2 ± 1.7 μm; range 4.1–11.3 μm; distal tip 8.9 ± 3.0 μm,
range 2.7–15.7 μm, n = 5 axons), compared to the cytosolic
labelled axons which underwent significant retraction on
both sides of the lesion site between 30 and 60min post le-
sion (GFP-M line, proximal tip 85.0 ± 37.9 μm; range 13.5–
264.2 μm; distal tip 82.4 ± 25.9 μm, range 22.1–185.4 μm,
n = 7 axons) (Additional file 4d).
When we returned to investigate the dynamics of cyto-
solic GFP in cortical axons using the GFP-M line, the
axoplasm of the distal disconnected cortical axon seg-
ments appeared to slowly retract away from the lesion
site over the first 60 min postlesion (Fig. 5b, c; 11.1 ±
1.9 μm; range 3–21 μm; n = 10 axons) [23, 24]. This is
potentially due to leakage of GFP from the cut end im-
mediately after the lesion and occurs before any frank
fragmentation of the distal axon.
Interestingly, in cortical axons the fragmentation rate
of membrane-bound GFP was much slower than the rate
of cytosolic GFP fragmentation (0.5 ± 0.1 μm/min versus
3.4 ± 0.7 μm/min, respectively; p < 0.05), and both were
slower than rates measured from previous studies in the
spinal cord [20] and phrenic nerve [12], which could po-
tentially be explained by the longer sampling intervals
used in our chronic in vivo imaging protocols.
Taken together, we describe novel approaches in the ex-
ploration of cortical axon WD in vivo. We identify a
threshold axon length below which the lag phase before
cortical axon fragmentation (here called ‘onset’) is one
order of magnitude earlier, and the fragmentation rate sig-
nificantly slower than for WD, in a process we call roWD.
In addition, in contrast to AAD [18, 20], roWD removes
the entire severed distal axon rather than just a portion of
Fig. 5 AAD is negligible in injured cortical axons in vivo. a No evidence of AAD within 60min of injury when the length of severed cortical axon
distal segments is monitored with a membrane marker (Thy1-L15). Note length stability in all but one axon (red line), indicating absence of
fragmentation over the first 60 min post-lesion (n = 16 axons, 7 mice). b Example of the retraction of the severed axon away from the lesion site
when observed with a cytosolic GFP marker (GFP-M line). Note the absence of fragmentation over the first 60 min post-lesion. Arrowheads
indicate intact axon. Axon ending is on the right edge of the frame. Scale bar = 10 μm. c Quantification of the distance from the lesion site to the
distal axon stump in cytosolic GFP labelled axons (Thy1-GFPM line) at the indicated post-lesion times (n = 10 axons, 7 mice)
Canty et al. BMC Biology          (2020) 18:170 Page 9 of 17
it adjacent to the lesion site and does not occur on the
proximal axonal segment (i.e. the portion still connected
to the cell body), revealing spatiotemporal differences in
degeneration between roWD and WD/AAD, summarised
in an Additional file (see Additional file 5).
Cortical axon WD is controlled by a local NAD+-
dependent pathway
To explore the mechanism of roWD, we investigated
NAD+-dependent signalling pathways, which have been
implicated in both WD and AAD [20, 49, 50] and in
modulating axon degeneration in several animal models
of neurodegenerative disease [1]. To this end, we used the
Wallerian degeneration slow (WldS) mouse line overex-
pressing a stable version of the NAD+ synthesising en-
zyme NMNAT1 consisting of an additional 18 amino acid
linkage to ubiquitination factor E4B, which has the effect
of delaying axon degeneration [50, 51]. Mice with the
WldS mutation have delayed onset of WD in both the per-
ipheral and central nervous system [52, 53]. WldS mice
were crossed with the Thy1-L15 line to produce heterozy-
gous WldS-Thy1-L15 progeny, and the cortical axon de-
generation kinetics were determined using the
aforementioned methodology in distal axons of < 600 μm
in length in WldS-Thy1-L15 (n = 24 axons, 11 mice,
Fig. 6a) and compared with wild-type (WT) axons of com-
parable length (n = 21 axons, 13 mice, Fig. 6b). WldS-Thy-
L15 animals showed a significantly delayed onset of frag-
mentation (Fig. 6c, WT, 1.7 ± 0.4 h; WldS-Thy1-L15, 7.6 ±
3.7 h, p < 0.01), indicating that roWD is regulated by
NAD+-dependent pathways. There was no significant dif-
ference in fragmentation rate, although there was a trend
for faster fragmentation in the WldS-Thy1-L15 cortical
axons (Fig. 6d; WT, 0.5 ± 0.1 μm/min; WldS-Thy1-L15,
Fig. 6 A local NAD+-dependent pathway controls cortical axon WD. a, b Representative examples of a lesioned WldS–Thy1-L15 and WT axons of
comparable distal length. c WldS axons have a significantly later fragmentation onset time than WT axons, WldS, n = 24 axons, 11 mice; WT n = 21
axons, 13 mice, ** p < 0.01. d The fragmentation rates are not significantly different in WT and WldS axons although the data suggested a trend
towards faster fragmentation in the WldS axons. e Representative images of a lesioned axon in cortical slice culture treated with NAD+. f
Fragmentation onset time in lesioned axons in cortical slice cultures is significantly earlier in axons < 600 μm (roWD, blue, n = 9 axons, 5 slices, 5
mice) than axons > 600 μm in length (WD, grey, n = 8 axons, 6 slices, 2 mice), *** p < 0.001. g–i Degeneration of in vitro lesioned axons with no
treatment (control, g), with addition of NAD+ prelesion (h) and postlesion (i). Blue dotted line shows the 24 h time point. j Axons are protected
by NAD+ when added both before or after the lesion. Mean ± SEM. Mann Whitney U test. Scale bar 70 μm (a, b), 100 μm (e)
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1.7 ± 0.5 μm/min, p = 0.0645). Interestingly, and unlike
WT axons, once fragmentation commenced, it did so
along the entire axonal length simultaneously.
To further probe NAD+-dependent regulation in cor-
tical axon degeneration, we used cortical explant cul-
tures to enable pharmacological manipulation of NAD+
levels [54]. Seventeen axons were lesioned, with mean
length of 613 ± 80 μm, from 6 animals (range 0.12–5
mm) (Fig. 6e, f). We verified that the onset of fragmenta-
tion of lesioned cortical axons in slice culture was com-
parable with the onset in in vivo experiments with a
significant delay in axons > 600 μm (Fig. 6f, g; onset =
1.8 ± 0.18 h, 9 axons < 600 μm; onset = 17.6 ± 2.48 h, 8
axons 600–1000 μm; p < 0.05). Fragmentation rates were
not calculated for the in vitro experiments as the room
temperature imaging conditions confounded the frag-
mentation kinetics [55]. Next, we tested whether the
protective effect of NAD+ was due to a local action on
the cut distal axon or to its potential role in modulating
gene expression in the nucleus [21, 26, 49]. To distin-
guish between these possibilities, we first applied 1 mM
NAD+ to a separate group of slice cultures 24 h before
the lesions, which resulted in a robust delay in roWD
onset (Fig. 6h, j; mean length 521 ± 51 μm, onset =
23.9 ± 3.5 h, n = 21 axons, 8 mice; p < 0.01 compared to
untreated mean length 613 ± 80 μm, onset = 9.2 ± 2.2 h,
n = 17 axons, 6 mice). To test the role of transcription-
independent NAD+ effects in the damaged neurons [49],
we also applied NAD+ immediately after the axon was
cut. In this case, NAD+ was also able to delay the onset
of degeneration (Fig. 6i, j; length = 613 ± 31 μm, onset =
30.9 ± 4.2 h, n = 23 axons, 10 mice; p < 0.01). These data
suggest that the NAD+ action is local, in agreement with
many other reports in the literature [50, 56, 57], rather
than requiring gene expression in the axotomised neu-
rons as shown for WD in a previous report in dissoci-
ated neuronal cultures [49].
Discussion
Here, we studied the spatiotemporal patterns and mech-
anisms of WD in the cerebral cortex. We combined
in vivo 2-photon time-lapse imaging of a fluorescent
membrane tracer through a cranial window and laser-
mediated lesions to track the full extent of WD for indi-
vidual unmyelinated cortical axonal arbours (Fig. 1). We
provide new insights into cortical axon degeneration: (1)
segments below ~ 600 μm in length consistently undergo
a faster form of WD (roWD); (2) synaptic density, but
not arbor complexity, contributes to the timing of cor-
tical axon WD; (3) AAD is negligible in lesioned cortical
axons; and (4) similar to WD in other parts of the ner-
vous system and AAD, an NAD+-dependent signalling
pathway, independent of transcription, delays cortical
axon roWD and WD.
In vivo optical imaging of spinal cord injury has pro-
vided unique insights into the mechanisms of axon de-
generation and regeneration in recent years [20, 23, 58].
However, we are only now starting to exploit this tool to
understand the principles of axon degeneration and re-
generation in the mammalian brain [37–39, 59–61].
Limitations of optical methods through glass windows to
induce local damage include the inability to model more
complex types of injury conditions such as those found
in traumatic brain injury or multiple sclerosis and the
difficulty of getting therapeutic compounds into the
brain in order to manipulate the local environment
in vivo [62]. There are three main advantages of laser-
mediated axonal transection compared to previously re-
ported methods. Firstly, laser microsurgery reveals the
entire degeneration process as close as 4–10 μm from
the injury site along to the terminal ending of the axon
[13, 38]. In contrast, following mechanical or needlestick
injury, anatomical distortions mean that axonal changes
can only be observed at a distance (> 100 μm) from the
injury site. Secondly, local axonal injury can be induced
without rupturing the dura mater and overlying blood
vessels, decreasing contributions from inflammatory me-
diators, thereby reducing the complexity of cellular in-
teractions and improving experimental reproducibility
[38, 63]. Thirdly, several neurons, or even parts of a
neuron [25], can be simultaneously targeted with min-
imal damage to the surrounding tissue [13, 36, 38, 64–
67]. The combination of this lesion method with the se-
lective monitoring of the axolemma, rather than the axo-
plasm as in previous studies, allowed us to accurately
measure the timing of the execution phases of axon de-
generation, ruling out instances of cytoplasmic fragmen-
tation not directly accompanied by loss of membrane
integrity (as reported previously [4, 15], and as our data
suggest it is the case for AAD, Fig. 5). These results indi-
cate that axoplasmic components such as microtubules
and neurofilaments are the first to change in WD, while
the axonal membrane persists for longer time, in agree-
ment with these previous reports [4, 15]. We expect that
this paradigm and its refinements, for example by simul-
taneously imaging cytoskeletal [68], mitochondria [69]
and membrane markers, will be useful to investigate
axonal degeneration in other mouse models of disease
(e.g. Alzheimer’s disease) or human-mouse chimeric
models, which employ patient-specific genetic back-
grounds [31, 70].
To our knowledge, ours is the first study to tackle the
challenge of monitoring the spatiotemporal dynamics, as
well as shedding light on the mechanisms, of WD in the
mammalian cerebral cortex at single axon resolution.
We used a labelling strategy targeted mainly to excita-
tory unmyelinated axons originating in cortical layer 2/
3/5/6 and the thalamus, because of their vulnerability in
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several neurodegenerative and acute injury conditions.
The reported degeneration kinetics fall within published
time frames for WD in the murine spinal cord [20],
peripheral nerves [71] and optic nerve [18], but reveal
that transected cortical axon segments < ~ 600 μm have
a different spatial and temporal degeneration progres-
sion pattern compared to both WD and AAD. Even
though only a small percentage (< 1%) of the axonal
arbor when lesioned undergoes roWD, roWD affects
up to 2–3 times more axon length than AAD [20] (see
Additional file 5).
In earlier work in zebrafish larvae, the length of the
disconnected axonal segment was not a critical param-
eter, not affecting the duration of the lag phase (which
we here call onset) and only slightly influencing the frag-
mentation rate [13]. The difference in fragmentation
rates between WD and roWD in mammalian cortical
neurons (Fig. 2d, g) could reflect the natural variability
of the degeneration process across species and the ner-
vous system. It is well established that degeneration kin-
etics are variable between axons in adults [11], and even
more so during development. For example, axotomised
trigeminal axons in the developing zebrafish show em-
bryonic stage-dependent differences in the time of the
degeneration onset and a distinct lack of AAD [13].
Other axon subtypes, such as those of the zebrafish lat-
eral line projections, do undergo a process resembling
AAD in that a gap rapidly forms on both sides of the
lesion, although no evidence of fragmentation was
detected [29].
For cortical axons, the timing of both the initiation
(onset, Fig. 2d, e) and execution phase (fragmentation
kinetics, Figs. 2d and 3c) differs depending on a cut-
off length of approximately 600 μm. Our data are not
consistent with a linear length-based mechanism to
explain the onset of cortical axon degeneration as
suggested by others who find that longer discon-
nected segments take longer to commence degener-
ation, for example in transected zebrafish trigeminal
axons [13]. A ‘threshold-dependent’ mechanism likely
controls cortical roWD and WD as illustrated in an
additional file (see Additional file 2). It could be ei-
ther a ‘protective factor’ or a ‘degeneration trigger
factor’ level-based threshold. For a ‘protective factor’
level-based threshold, the amount of a degeneration
inhibitor (e.g. NAD+, or neuro-protective NAD syn-
thesising enzyme Nmnat2 [14, 72, 73]) would de-
crease [74] below a critical threshold level before
termination of the broken membrane resealing
process (which can occur within 30 min post injury
in vitro [75]), triggering rapid onset of fragmentation.
In longer segments, the membrane from the cut end
would reseal before depletion, and as such, these frag-
ments persist. For a ‘degeneration trigger factor’ level-
based threshold, a critical amount of a trigger such as
calcium influx (e.g. via downstream effectors such as
calpains [76]), mediated by extracellular calcium in-
flux through the cut end [77, 78], would be rapidly
reached in shorter segments which would therefore
fragment quickly compared to longer segments. The
rapid removal of short, damaged axonal segments
from the neuropil may have evolved as a mechanism
to rapidly restore brain homeostasis and keep the
neuropil free from debris.
Our results on the regulation of cortical roWD and
WD by NAD+-dependent mechanisms (Fig. 6) are con-
sistent with previous data of delayed dopaminergic and
striatal synaptic degeneration in WldS mice [79, 80], pro-
viding additional in vivo evidence that WldS-based neuro-
protective therapeutics may be developed not only for
myelinated but also for unmyelinated, grey matter fibre
degeneration. These results demonstrate further conserva-
tion of the molecular mechanisms controlling WD, des-
pite different spatiotemporal patterns of degeneration in
different areas of the mammalian nervous system [26].
Cortical axons have more delayed degeneration onset
the higher the density of synaptic connections (Fig. 4).
Synapse loss in neurodegeneration can occur independ-
ently of axonal and cell body loss, suggesting that differ-
ent mechanisms regulate the degeneration of these
compartments [81–83]. We hypothesise that the pres-
ence of synapses limits the depletion of axon protective
factors or accumulation of degeneration triggers, pos-
sibly through either slower diffusion along the axon, or
due to being crosslinked with synaptic machinery,
prolonging the lag phase before fragmentation.
In the future, the in vivo optical imaging approach
used here could lead to a better understanding of the
molecular and cellular mechanisms that regulate cortical
axon degeneration, a necessary step in the development
of effective therapies to counteract or stabilise the pro-
gression of axon and synaptic loss in both the diseased
and injured brain.
Conclusions
We identify a rapid onset form of Wallerian Degener-
ation (roWD) in injured cortical axons shorter than
600 μm in length, which is dependent on synaptic dens-
ity but not axon complexity nor the position of the sev-
ered segment along the axon shaft. In addition, we find
that NAD+ signalling mechanisms regulate both cortical
WD and roWD, demonstrating further conservation of
the molecular mechanisms controlling WD in different
areas of the mammalian nervous system. Our data high-
light the potential for in vivo 2-photon time-lapse im-
aging to further investigate axonal degeneration and
importantly to assess therapeutic interventions in the in-
jured mammalian brain.
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Methods
Animals
Adult male mice from Thy1-L15 [48] (membrane-tar-
geted GFP, n = 32, 12–14 weeks), Thy1-GFPM [48]
(cytosolic-targeted GFP, n = 12, 12–14 weeks) and the
WldS line, which spontaneously expresses the slow Wal-
lerian degeneration mutation (WldS-Thy1-L15, n = 11,
12–14 weeks), were used for all in vivo imaging experi-
ments unless otherwise specified. All mice were given
access to food and water ad libitum and maintained in a
12-h light-dark cycle. All animal procedures were con-
ducted at the Institute of Clinical Sciences, Imperial Col-
lege London, by researchers holding a UK personal
licence; conducted in accordance with the UK Animals
(Scientific Procedures) Act 1986; and approved by the
local Animal Welfare and Ethical Review Body (AWERB).
Craniotomy
Cranial windows were surgically implanted over the som-
atosensory cortex as previously described [43]. Mice were
anaesthetized with ketamine-xylazine intraperitoneal in-
jection (0.083mg/g ketamine, 0.0078mg/g xylazine) and
then administered intramuscular dexamethasone (0.02ml
at 4mg/ml) to reduce inflammation, and subcutaneous
bupivacaine (1mg/kg), a local anaesthetic. A few drops of
lidocaine (1% solution) were applied on the skull surface
prior to a 5-mm diameter craniotomy being drilled over
the somatosensory cortex. A glass coverslip was then
placed over the craniotomy and sealed with glue and den-
tal cement. The skull was subsequently covered in dental
cement and a metal bar placed on top for positioning at
the two-photon microscope. Mice were allowed to recover
for 14 days prior to imaging.
Two-photon imaging in vivo
A purpose built two-photon microscope (Prairie Tech-
nologies) equipped with a tunable Ti:Sapphire laser (Co-
herent) and PrairieView acquisition software was used
for all imaging experiments. Mice were anaesthetized
with isofluorane (1–1.5%) and secured to the microscope
with the head metal bar attached to a custom-built fixed
support. Lacri-lube was applied to the eyes to prevent
dehydration and temperature maintained by a heating
blanket. An Olympus 4X objective with a 0.13 numerical
aperture (NA) was used to identify characteristic blood
vessels to reliably locate regions of interest (ROIs) at
each imaging time point. An Olympus 40X (NA = 0.8)
water immersion objective was used to acquire several
ROI stacks per animal (typically 100 × 100 μm field of
view, 512 × 512 pixels, 1-μm step size). A pulsed 910-nm
laser beam was used with typical power never exceeding
70mW on the back focal plane. Each imaging session
lasted a maximum of 90min, after which animals recov-
ered for at least 30 min before the next session began.
Selection of cortical axons and laser-mediated axonal
lesions in vivo
A total of 154 axons (93 in vivo and 61 in vitro) were le-
sioned and followed for up to 153 h in vivo and 96 h
in vitro to assess axon degeneration kinetics. Axons lo-
cated in the upper layers of the cortex were selected
starting from their tips/endings, then followed along the
axon shaft towards the cell body for as long as axon
identification could be guaranteed, until the axon disap-
peared under a blood vessel, under the bone edges or
could not be distinguished from neighbouring axons,
which defined axonal segments of variable length. A
laser micro-lesion protocol was optimised to induce a
reproducible lesion as in [38, 39]. Briefly, the imaging
laser was tuned to 800 nm and engineered to deliver a
single spot scan to a previously identified axon, severing
the axon shaft. Lesions were conducted in layer-1 of the
cortex within 50 μm of the pial surface. Care was taken
to lesion away from large vessels to avoid any confound-
ing effects of the breakdown of the blood-brain-barrier.
Complete axotomy was confirmed in each case by the
eventual disappearance of the disconnected distal axon
segment. The length of the disconnected axon was mea-
sured from the edge of the lesion site to the distal end-
ing using Fiji software. Between 1 and 5 axons were
selected for lesion in each brain, with lesions separated
spatially and/or temporally, depending on the labelling
pattern and density, maintained clarity of the imaging
window and the number of anaesthetic/imaging sessions
required.
Repeated imaging of axon degeneration in vivo
Since it was not possible to predict when the axon
fragmentation process would start, cortical axons were
imaged before the lesion and at variable intervals after
the lesion, until at least 50% of the disconnected axon
had disappeared. On average, 89.6 ± 13.9% of the axon
length disappeared over 5.5 time points per axon
(range 3–21 imaging sessions, n = 43 in vivo cortical
axons). To ensure the welfare of the animals over the
prolonged imaging sessions, which lasted up to 6 days,
while still ensuring accurate measurements of the
fragmentation kinetics, imaging intervals were kept to
less than 5 h between sessions (i.e. the maximum
interval between any two consecutive sessions was 5
h). As a result, the average time interval recorded
after fragmentation onset was 103 min. Therefore, the
maximum fragmentation speed we could measure, on
average, for a segment undergoing roWD is ~
300 μm/103 min = ~ 3 μm/min, and for a segment
undergoing WD, ~ 1000/103 = ~ 10 μm/min. This
equates to a situation where the axonal segment is
entirely removed between two consecutive time
points. In a subset of cases, reducing the imaging
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interval after fragmentation onset, to an average of
13 min between images (with a minimum of 4 images
collected during the fragmentation phase for any
axon; average 9 images, range 4–16), however, did
not significantly change the measured fragmentation
rates (for < 600 μm length axons: 0.6 ± 0.1 μm/min;
n = 8; p > 0.05 compared to segments < 600 μm imaged
on average every 103 min) and onset (160 ± 24 min;
n = 8 segments imaged with less than 2 h intervals;
p > 0.05 compared to segments < 600 μm imaged with
less than 4 h intervals), confirming our methodology.
A subset of axons (n = 16 imaged with a membrane
marker and 10 with an axoplasm one) were imaged
more frequently for the first 60 min to probe for
AAD. These experiments, which consisted of higher
number of imaging time points acquired, also rule
out any contribution of photo-bleaching of either
membrane-bound or cytosolic GFP to the interpret-
ation of degeneration kinetics.
After the final imaging session, mice were adminis-
tered a lethal dose of ketamine/xylazine and transcar-
dially perfused with ice-cold saline followed by 4%
paraformaldehyde. Brains were removed and post-fixed
overnight in paraformaldehyde at 4 °C before being
transferred to 0.01M PBS and stored in the fridge.
Laminectomy and spinal cord imaging
Dorsal laminectomy was performed at lumbar spinal
levels 1–3 prior to two-photon imaging in a non-
recovery surgical procedure. Mice (Thy1-L15 n = 5,
Thy1-GFPM n = 5) were anaesthetized with intraperito-
neal injection of ketamine-xylazine mixture (0.083mg/g
ketamine, 0.0078 mg/g xylazine). After shaving the back,
a longitudinal incision was made to retract the skin. The
peri-vertebral muscles were deflected to expose the ver-
tebral column and the laminae were removed using
curved blade scissors. The mouse was then moved care-
fully to the microscope stage. The trunk was raised
slightly and the vertebral column was clamped between
two custom made bars for stabilisation during 2-photon
imaging. The area surrounding the exposed spinal cord
was circled by a layer of veterinary n-butyl cyanoacrylate
adhesive to facilitate the formation of a saline meniscus
between the objective and the exposed spinal cord. La-
belled ascending axons in the dorsal white matter tracts
were targeted for micro-lesion. The anaesthesia level
was maintained by inhalation of an oxygen and isoflur-
ane mixture (1.5–2.5%) throughout the imaging sessions.
Mice were administered a lethal dose of ketamine/xyla-
zine at the conclusion of the imaging session and trans-
cardially perfused with ice-cold saline followed by 4%
paraformaldehyde.
Organotypic cortical slice culture preparation
Organotypic slices were prepared from the brains of
neonatal transgenic mice (Thy1-L15, described above)
based on [54]. Pups (n = 29) were killed at postnatal day
(P) 3–4 by decapitation. Brains were carefully removed
and immediately submerged in ice-cold culture medium
(MEM Hanks supplemented with 20% heat-inactivated
horse serum, Penicillin/Streptomycin (1%), Insulin (1 μg/
ml), CaCL2 (1 mM), MgSO4 (2 mM), ascorbic acid
(1.2%)). The cortical hemispheres were dissected away
from the diencephalon and cortical slices (400 μm) were
obtained with a McIlwain Tissue Chopper (Laboratory
Engineering Co. Ltd., UK). Slices were carefully trans-
ferred, using a fire-polished, wide bore glass Pasteur pip-
ette, to 35-mm petri dishes containing fresh, ice-cold
culture medium and incubated on ice for 40 min. Using
a dissection microscope, slices containing the somato-
sensory cortex were carefully transferred to Millicell cul-
ture plate inserts (Millipore) and incubated for up to 2
months with 1-ml culture medium at 35 °C in a humidi-
fied atmosphere with 5% CO2. The culture medium was
changed twice weekly throughout the culture period.
Imaging of axon degeneration in organotypic slice
cultures
Organotypic slice cultures were imaged using two-
photon microscopy beginning at 21–28 days in vitro
(DIV). Culture inserts containing slices were transferred
to sterile 35-mm petri dishes containing 1 ml pre-
warmed Tyrodes salt solution (Sigma), and a further 1
ml was added on top of the slice. Imaging sessions of up
to 1.5 h, using low power (< 20mW at the back focal
plane), were possible without noticeable deleterious ef-
fects in the slice. Typically 1–4 axons were chosen per
slice (maximum length, 5 mm). Laser-mediated micro-
lesions were performed as described for in vivo imaging
protocols. To investigate the effects of NAD+ on the dy-
namics of axonal degeneration, slices were incubated for
24 h pre- or postlesion, with medium containing 1 mM
NAD+ or with medium alone. Following imaging and/or
lesioning, the salt solution was carefully removed from
above and below the membrane and the inserts were
returned to the incubator with fresh, pre-warmed cul-
ture medium (with or without NAD+, as appropriate).
Experimental design and statistical analysis
Our experimental design involves longitudinal imaging
to analyse cellular dynamics before and after a laser-
mediated microlesion. The experimental design and stat-
istical analysis of the data was discussed with in-house
biostatisticians prior to commencement of analysis. Sam-
ple sizes have been set by power calculations in Pass
software, using a significance threshold of 5% and a
power of 80%. Previous experience of published
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experimental systems including ours indicates that data
points are not normally distributed (normality tests were
used) and tests compared two conditions within the
same animals (before and after the lesion). Hence statis-
tical significance was calculated by Mann-Whitney U
test.
Data analysis
Maximum projections of individual image stacks from
in vivo and in vitro two-photon images of axons from all
mice were processed with Fiji (file conversions, length
quantifications) and Adobe Photoshop (section align-
ment, image rotation, brightness and contrast adjust-
ment). Bouton density was determined by annotating
Terminaux Boutons (TBs) in Matlab using custom made
software [45, 84]. TBs (defined as protrusions between 1
and 5 μm) were scored according to stringent criteria
based on [43] and [45]. In previous work, we performed
correlated 2-photon : electron microscopy to confirm
the presence of complete synaptic connections corre-
sponding to imaged boutons along the same type of cor-
tical axons as in the present study [38, 44, 45].
The resolution of our multiphoton microscope (0.25 ×
0.25 × 2.5 in X-Y-Z) is sufficient to resolve gaps along
the axons of few microns. Axons were excluded from
analysis in cases where the visibility was compromised
(e.g. by low window clarity, high axon labelling density
or weak GFP signal).
The length of the distal portions from the edge of the
lesion mask to the terminal ending was measured for all
axons. ‘Ending’ and ‘close to the lesion’ were used to de-
scribe each end of the disconnected axon where ending
refers to the terminal ending of the axon. Axons were
grouped as either unbranched or branched, where the
total length was less than or more than 600 μm.
Figures were prepared using Microsoft Office Suite,
Adobe Illustrator and BioRender.
Statistical analyses were performed in Microsoft Excel,
R or GraphPad Prism. Unless otherwise stated, all mea-
surements are given as the mean ± standard error of the
mean (SEM). Student’s t tests or Mann Whitney U tests
were performed, unless otherwise stated. Results were
considered significant when p < 0.05.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12915-020-00869-2.
Additional file 1. Canty et al. Additional file 1.pdf. Examples of
fragmenting cortical axons. (a, b) Representative images and tracings of
two short axon endings undergoing rapid onset WD (roWD) with time
post-lesion and percentage of axon lost indicated. (c) Representative im-
ages and tracings of a branched, longer axon undergoing Wallerian de-
generation (WD) with time post-lesion and percentage of axon lost
indicated. Dotted boxes refer to the axon segments shown below. Scale
bar is 20 μm in a, 25 μm in b and 32 μm in c.
Additional file 2. Canty et al. Additional file 2.pdf. Probing the onset
mechanism of lesioned axons. Schematic depiction of ‘protective factor’
and ‘degeneration trigger factor’ regulated axon degeneration paradigms
following a single or double lesion. Lightning bolt represents lesion site.
Purple arrows indicate movement of protective factor out of the lesioned
axon via one (single lesion) or two routes (double lesion). Red arrows
indicate movement of a degeneration trigger into the lesioned axon via
one (single lesion) or two routes (double lesion).
Additional file 3. Canty et al. Additional file 3.mov. Time-lapse movie of
axon degeneration in the living mouse brain. This movie shows the
degeneration of a distal axon fragment over time in the mouse cerebral
cortex as viewed via a cranial window preparation. Post-lesion time
stamps are indicated on each frame.
Additional file 4. AAD involves axoplasmic but not axolemmal
fragmentation in spinal cord sensory axons after axotomy. (a)
Axoplasmic fragmentation, AAD, occurs after laser-mediated lesion of
ascending sensory neurons expressing a cytosolic form of GFP (white
arrowhead at + 65 min, n = 9 axons, 5 mice). (b) Axons remain intact
for longer in ascending Thy1-L15 sensory axons expressing a
membrane-bound form of GFP (n = 9 axons, 5 mice). Note beading
of axons, but no fragments for up to ~ 2 h postlesion. (c) The mean
onset of sensory axon fragmentation is significantly shorter for GFP-M
(cytosolic GFP) compared to L15 (membrane-targeted GFP) axons. (d)
Mean distance of severed proximal and distal axon tips to the lesion
site in GFP-M (cytosolic GFP, n = 9 axons, blue lines) and L15 (mem-
brane-targeted GFP, n = 9 axons, orange lines). Scale bar 50 μm for a
and b. *** p < 0.001.
Additional file 5. Axon degeneration modalities. Schematic depicts the
characteristics of axon degeneration for acute axonal degeneration in the
spinal cord (AAD, green), rapid onset Wallerian degeneration in the
cortex (roWD, blue) and Wallerian degeneration (WD) in the cortex (grey)
and spinal cord (pink). From top to bottom, illustrated degeneration
characteristics include the site of injury along the axon, the length of
disconnected axon, the onset time at which fragmentation commences,
and the fragmentation rate.
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